Stars Struck by 'Ozempic Face' in 2025

In 2025, a noticeably thinner, but gaunt, face became a common sight in Hollywood. This was attributed to the use of rapid weight loss drugs, which led to a condition known as 'Ozempic face'. The drugs affected facial fat and skin health, causing sagging and impacting rejuvenation.

The year 2025 saw many in Hollywood sporting thinner faces, though often with a gaunt appearance and reduced elasticity. While celebrities discovered a new path to thinness, their access to youthful looks seemed to diminish. Even strong Botox and fillers couldn't combat the sagging caused by rapid weight loss drugs.

Beverly Hills plastic surgeon Dr. Samuel Golpanian explained that "GLP-1 drugs can reduce not only deeper facial fat, which provides youthful volume, but also a special layer under the skin called white adipose tissue (WAT). This tissue contains stem cells that produce growth factors, cytokines, and hormones essential for skin health." He discussed striking cases of celeb "Ozempic face" in August. According to Dr. Golpanian, these drugs affect "both the skin's structure and its ability to rejuvenate" over time. Health tracking apps like Shotlee can help monitor changes that might indicate these effects.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

In 2025, numerous celebrities experienced this weight loss drug-induced aesthetic. This was due to the adverse side effects of rapid weight loss.

Source Information

Originally published by NickiSwift.com.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies

Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.

7 min read

Health & Wellness

Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means

Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.

9 min read

Health & Wellness

Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine

New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.

8 min read

Same topic: celebrity news

All celebrity news articles →

Entertainment

Internet Claims Meghan Trainor Looked 'Off,' More Slender Post-Mounjaro

Meghan Trainor's slimmer appearance, attributed to Mounjaro, has ignited online discussions. While some celebrate her health dedication, others miss her earlier look. The debate highlights body image and societal pressures.

2 min read

More in Entertainment

Health & Wellness

GLP-1 Drugs and Vision Loss: Understanding NAION Lawsuits

Recent lawsuits are raising serious questions about the potential for GLP-1 medications, widely used for diabetes and weight loss, to cause a rare but devastating eye condition known as NAION, leading to permanent vision loss. This article delves into the allegations, scientific evidence, and ongoing legal proceedings.

6 min read

Health & Wellness

Beyond Weight Loss: Surprising Health Benefits of GLP-1 Drugs

While widely recognized for their effectiveness in weight management, GLP-1 receptor agonists are revealing a spectrum of profound health benefits. Discover how these groundbreaking medications are impacting cardiovascular health, kidney function, liver disease, and even potentially neurodegenerative conditions.

7 min read

Healthcare Policy

Supreme Court Ruling: Medicare Drug Price Negotiations Move Forward

In a significant victory for healthcare cost containment, the Supreme Court has allowed Medicare to proceed with negotiating drug prices. This decision upholds a key provision of the Inflation Reduction Act and could impact the cost of many prescription medications, including widely used GLP-1 agonists.

6 min read